Abstract
Surgery has been used to manage various disease processes for hundreds of years. Advanced body cavity operations, however, did not become possible until the beginning of the twentieth century, when the discovery of ether anesthesia enabled surgeons to perform prolonged operations, organ extirpations, and reconstructive surgeries. Some of the major accomplishments of the early twentieth century included Billroth’s pioneering of surgical techniques and strategies for the management of gastric cancer and Halsted’s use of radical mastectomy with extensive lymph node dissection for breast cancer [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ravitch MM. Carcinoma of the breast: the place of the Halsted radical mastectomy. Johns Hopkins Med J. 1971;129(4):202–11.
Dubecz A, Schwartz SI. Franz John A. Torek. Ann Thorac Surg. 2008;85(4):1497–9.
Orringer MB. Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg. 1984;200(3):282–8.
Peterson BE, Chissov VI, Mamontov AS, Pavlov IN. One-stage resection of the cardia and esophagus with delayed extracavitary neck anastomosis in cancer. Khirurgiia (Mosk). 1982;(5):29–32. Russian.
Altorki NK, Skinner DB. En bloc esophagectomy: the first 100 patients. Hepatogastroenterology. 1990;37(4):360–3.
Luketich JD, Alvelo-Rivera M, Buenaventura PO, Christie NA, McCaughan JS, Litle VR, Schauer PR, Close JM, Fernando HC. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg. 2003;238(4):486–94.
Park SY, Kim DJ, Yu WS, Jung HS. Robot-assisted thoracoscopic esophagectomy with extensive mediastinal lymphadenectomy: experience with 114 consecutive patients with intrathoracic esophageal cancer. Dis Esophagus. 2015. doi:10.1111/dote.12335.
Mathisen DJ, Grillo HC, Wilkins Jr EW, Moncure AC, Hilgenberg AD. Transthoracic esophagectomy: a safe approach to carcinoma of the esophagus. Ann Thorac Surg. 1988;45(2):137–43.
Peyre CG, DeMeester TR. Vagal-sparing esophagectomy. Adv Surg. 2008;42:109–16.
Jobe BA, Reavis KM, Davis JJ, Hunter JG. Laparoscopic inversion esophagectomy: simplifying a daunting operation. Dis Esophagus. 2004;17(1):95–7.
Martin JT, Mahan A, Zwischenberger JB, McGrath PC, Tzeng CW. Should gastric cardia cancers be treated with esophagectomy or total gastrectomy? A comprehensive analysis of 4,996 NSQIP/SEER patients. J Am Coll Surg. 2015;220(4):510–20.
Baba M, Aikou T, Yoshinaka H, Natsugoe S, Fukumoto T, Shimazu H, Akazawa K. Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg. 1994;219(3):310–6.
Gillies RS, Simpkin A, Sgromo B, Marshall RE, Maynard ND. Left thoracoabdominal esophagectomy: results from a single specialist center. Dis Esophagus. 2011;24(3):138–44.
Rutegård M, Lagergren P, Johar A, Lagergren J. Time shift in early postoperative mortality after oesophagectomy for cancer. Ann Surg Oncol. 2015;22(9):3144–9.
van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A, CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84. doi:10.1056/NEJMoa1112088.
Arnott SJ, Duncan W, Gignoux M, Girling DJ, Hansen HS, Launois B, Nygaard K, Parmar MK, Roussel A, Spiliopoulos G, Stewart LA, Tierney JF, Mei W, Rugang Z. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys. 1998;41:579–83.
Teniere P, Hay JM, Fingerhut A, Fagniez PL. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gyn Obstet. 1991;173:123–30.
Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL, University of Texas MD Anderson Esophageal Cancer Group. The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg. 2013;258(3):500–7.
Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg. 1988;96:242–8.
Kelsen DP, Winter KA, Gunderson LI, Mortimer J, Norman CE, Haller DG, Ajani JA, Kocka W, Minsky BD, Roth JA, Willett CG. Long-term results of RTOG trial 8911 (USA intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol. 2007;25:3719–25.
Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet. 2002;359:1727–33.
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van De Velde CJH, Nicholson M, Scarffe H, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.
Stahl M, Walz MK, Stuschke M, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally-advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 2009;27:851–6.
Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, North J, Walpole ET, Denham JW, Trans-Tasman Radiation Oncology Group, Australasian Gastro-Intestinal Trials Group. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol. 2005;9:659–68.
Kim JY, Correa AM, Vaporciyan AA, Roth JA, Mehran RJ, Walsh GL, Rice DC, Ajani JA, Maru DM, Bhutani MS, Welsh J, Marom EM, Swisher SG, Hofstetter WL. Does the timing of esophagectomy after chemoradiation affect outcome? Ann Thorac Surg. 2012;93(1):207–12.
Swisher SG, Winter KA, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG. A phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246. Int J Radiat Oncol Biol Phys. 2012;82(5):1967–72. doi:10.1016/j.ijrobp.2011.01.043. Epub 2011 Apr 18.
Chang AC, Orringer MB. Management of cervical esophagogastric stricture. Semin Thorac Cardiovasc Surg. 2007;19(1):66–71. Review.
Sepesi B, Swisher SG, Walsh GL, Correa A, Mehran RJ, Rice D, Roth J, Vaporciyan A, Hofstetter WL. Omental reinforcement of the thoracic esophagogastric anastomosis: an analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy. J Thorac Cardiovasc Surg. 2012;144(5):1146–50. doi:10.1016/j.jtcvs.2012.07.085. Epub 2012 Aug 28.
Martin LW, Swisher SG, Hofstetter W, Correa AM, Mehran RJ, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. Ann Surg. 2005;242(3):392–9; discussion 399–402.
Blackmon SH, Correa AM, Wynn B, Hofstetter WL, Martin LW, Mehran RJ, Rice DC, Swisher SG, Walsh GL, Roth JA, Vaporciyan AA. Propensity-matched analysis of three techniques for intrathoracic esophagogastric anastomosis. Ann Thorac Surg. 2007;83(5):1805–13; discussion 1813.
Stiles BM, Mirza F, Port JL, Lee PC, Paul S, Christos P, Altorki NK. Predictors of cervical and recurrent laryngeal lymph node metastases from esophageal cancer. Ann Thorac Surg. 2010;90(6):1805–11.
Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Hofstetter WL, Watson TJ, Allen MS, Rusch VW, Blackstone EH. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251(1):46–50.
Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Skinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies. J Clin Oncol. 2013;31(34):4306–10. doi:10.1200/JCO.2013.51.7250. Epub 2013 Oct 21.
Sudo K, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Taketa T, Blum MA, Lee JH, Bhutani MS, Weston B, Ross WA, Komaki R, Rice DC, Swisher SG, Hofstetter WL, Maru DM, Skinner HD, Ajani JA. Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer. J Clin Oncol. 2014;32(30):3400–5. doi:10.1200/JCO.2014.56.7156. Epub 2014 Sept 15.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Sepesi, B., Hofstetter, W. (2016). Advanced Surgical Approaches for the Management of Esophageal Carcinoma. In: Ozyigit, G., Selek, U., Topkan, E. (eds) Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-319-28761-4_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-28761-4_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28759-1
Online ISBN: 978-3-319-28761-4
eBook Packages: MedicineMedicine (R0)